Literature DB >> 8972195

The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.

A Brehm1, K Ohbo, H Schöler.   

Abstract

The POU transcription factor Oct-4 is expressed in totipotent and pluripotent cells of the early mouse embryo and the germ cell lineage. Transactivation capacities of regions flanking the DNA binding domain of Oct-4 were analyzed in undifferentiated and differentiated cell lines. The amino- and carboxy-terminal regions (N domain and C domain) fused to the Gal4 DNA binding domain both functioned as transactivation domains in all cell lines tested. However, the C domain failed to activate transcription in some cell lines in the context of the native protein. The underlying regulatory mechanism appears to involve the POU domain of Oct-4 and can discriminate between different POU domains, since constructs in which the C domain was instead fused to the POU domain of Pit-1 were again equally active in all cell lines. These results indicate that the C domain is subject to cell-type-specific regulation mediated by the Oct-4 POU domain. Phosphopeptide analysis revealed that the cell-type-specific difference of C-domain activity correlates with a difference in Oct-4 phosphorylation status. Since Oct-4 is expressed in a variety of distinct cell types during murine embryogenesis, these results suggest an additional regulatory mechanism for determining Oct-4 function in rapidly changing cell types during development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8972195      PMCID: PMC231739          DOI: 10.1128/MCB.17.1.154

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.

Authors:  S Minucci; V Botquin; Y I Yeom; A Dey; I Sylvester; D J Zand; K Ohbo; K Ozato; H R Scholer
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

2.  A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein.

Authors:  C Scheidereit; J A Cromlish; T Gerster; K Kawakami; C G Balmaceda; R A Currie; R G Roeder
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

3.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

4.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity.

Authors:  T Wirth; L Staudt; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

5.  Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.

Authors:  Y Luo; R G Roeder
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

6.  Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain.

Authors:  X Y Li; M R Green
Journal:  Genes Dev       Date:  1996-03-01       Impact factor: 11.361

7.  Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a.

Authors:  E M Friedl; P Matthias
Journal:  Eur J Biochem       Date:  1995-11-15

8.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

9.  Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1.

Authors:  M A Vigano; L M Staudt
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

10.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.

Authors:  Y I Yeom; G Fuhrmann; C E Ovitt; A Brehm; K Ohbo; M Gross; K Hübner; H R Schöler
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  38 in total

1.  Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.

Authors:  A Brehm; K Ohbo; W Zwerschke; V Botquin; P Jansen-Dürr; H R Schöler
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  Oct4 was a novel target of Wnt signaling pathway.

Authors:  Jun Li; Jingyi Li; Bingbo Chen
Journal:  Mol Cell Biochem       Date:  2011-11-26       Impact factor: 3.396

5.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.

Authors:  D C Ambrosetti; C Basilico; L Dailey
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Novel variants of Oct-3/4 gene expressed in mouse somatic cells.

Authors:  Nobuhiko Mizuno; Mitsuko Kosaka
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

7.  Sodium butyrate facilitates reprogramming by derepressing OCT4 transactivity at the promoter of embryonic stem cell-specific miR-302/367 cluster.

Authors:  Zhonghui Zhang; Di Xiang; Wen-Shu Wu
Journal:  Cell Reprogram       Date:  2014-02-25       Impact factor: 1.987

8.  Gene structure and identification of minimal promoter of Pou2 expressed in spermatogonial cells of rohu carp, Labeo rohita.

Authors:  Chinmayee Mohapatra; Swagat Kumar Patra; Rudra Prasanna Panda; Ramya Mohanta; Ashis Saha; Jatindra Nath Saha; Kanta Das Mahapatra; Pallipuram Jayasankar; Hirak Kumar Barman
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

9.  Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Authors:  Paula Sotomayor; Alejandro Godoy; Gary J Smith; Wendy J Huss
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

10.  EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.

Authors:  S Kim; B Lim; J Kim
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.